Article

Lee, H.J., Jeong, G., Li, H., Kim, M., Kim, J., Park, S.J., Han, Y.J., Lee, K.H., Kronbichler, A., Hong, S.H., Ghayda, R.A., Luchini, C., Nottegar, A., Koyanagi, A., Smith, L., Jacob, L., Dragioti, E., Radua, J., Cargnin, S., Terrazzino, S., Thompson, T. ORCID: https://orcid.org/0000-0001-9880-782X, Yon, D.K., Lee, S.W., Yang, J.M., Wasuwanich, P., Shin, J.L. and Gamerith, G. (2021) Efficacy and safety of epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) monotherapy for advanced EGFR-mutated non-small cell lung cancer: systematic review and meta-analysis. European Review for Medical and Pharmacological Sciences, 25 (20). pp. 6232-6244. ISSN 1128-3602 (doi:10.26355/eurrev_202110_26993)